223127-23-9

Usage

Uses

Used in Pharmaceutical Synthesis:
6-(4-Methoxyphenyl)-nicotinic acid is used as a key building block in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic benefits.
Used in Agrochemical Production:
In the agrochemical industry, 6-(4-Methoxyphenyl)-nicotinic acid is utilized as a component in the creation of compounds designed to protect crops and enhance agricultural productivity.
Used in Anti-inflammatory Applications:
6-(4-Methoxyphenyl)-nicotinic acid is employed as an anti-inflammatory agent due to its potential to reduce inflammation, which can be beneficial in treating a variety of conditions affected by inflammatory processes.
Used in Antioxidant Formulations:
Leveraging its antioxidant properties, 6-(4-Methoxyphenyl)-nicotinic acid is used in formulations aimed at neutralizing free radicals and protecting the body from oxidative stress, which can contribute to aging and various diseases.
Used in Diabetes Treatment Research:
6-(4-Methoxyphenyl)-nicotinic acid is being studied for its potential role in diabetes treatment, possibly aiding in the management of blood sugar levels and improving the overall health of diabetic patients.
Used in Cancer Therapy Research:
6-(4-Methoxyphenyl)-nicotinic acid is also being explored for its potential contribution to cancer therapy, with research focusing on its ability to target and treat cancer cells, offering a new avenue for cancer treatment strategies.

Upstream product

• 5326-23-8 6-Chloro-3-pyridinecarboxylic acid 
• 5720-07-0 4-methoxyphenylboronic acid 

Downstream Products

• 223126-04-3 ethyl 2-(4-isopropylphenoxy)-3-[4-[2-[6-(4-methoxyphenyl)pyridine-3-carbonylamino]ethoxy]phenyl]-2-methylpropionate 
• 1364667-02-6 benzyl 6-(4-methoxyphenyl)nicotinate 
• 223125-54-0 ethyl 2-(4-isopropylphenoxy)-3-[4-[2-(2-(4-methoxyphenyl)-pyridine-5-carbonylamino)ethoxy]phenyl]propionate 

Relevant academic research and scientific papers

Novel heteroarylcarboxamide derivative or pharmacutically acceptable salt thereof, process for the preparation thereof and pharmaceutical composition for prevention or treatment of RAGE receptor related diseases containing the same as an active ingredient

The present invention refers to novel heterocyclic biting Carbox probably the id derivative acceptable salt, and manufacturing method thereof including RAGE associated active acetylcholinesterase receptor or pharmaceutical composition for preventing or treating disease is directed to. Heterocycle by the present invention a derivative biting Carbox probably the id RAGE receptor antagonism in by, nerve cells with the beta loss oh with wheat id RAGE conjunction with receptor, inhibiting moving into brain, the resulting beta Amyloid plaque formed 21 is known to effectively inhibit generation.. Furthermore, memory a chemicals that are important in the acetylcholine for decomposing an aromatic thus inhibiting acetylcholine s reel sacrifice , RAGE disease associated active acetylcholinesterase receptor or Alzheimer's disease, cerebrovascular dementia, dementia due to damage bean curd, multi blockade dementia, Alzheimer's disease or the like dementia alcoholic or mixed dementia multi blockade and including dementia, pick (pick) bottle, a smartcrew [...] -Jakob (Creutzfeldt-jakob) bottle, that thyroid gland symptoms , bean curd a blade Parkinson (Parkinson) bottle, Huntington's disease (Huntington) which is useful in preventing or treating, can be used.

PIPERIDINES USEFUL FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

The invention relates to compounds which are substituted chiral or achiral derivatives of 3- or 4- aminopiperidine of the general formula (I). The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more compounds of general formula I and especially their use as inhibitors of β-secretases.

Solid-phase Suzuki cross-coupling reactions using a phosphine ligand based on a phospha-adamantane framework

The use of a catalyst system based on Pd2dba3· CHCl3 and 1,3,5,7-tetramethyl-2,4,8-trioxa-6-phenyl-6-phospha- adamantane allows for Suzuki coupling aryl halides with an array of boronic acids on a solid-phase platform. The reactions can be carried out at room temperature with low palladium loadings in high yields.

Amidocarboxylic acid derivatives

Amidocarboxylic acid derivatives of the formula: wherein R1 represents a hydrogen atom, etc.; R2 represents an alkylene group; R3 represents a hydrogen atom, etc.; R4 represents a hydrogen atom, etc.; X represents a substituted or unsubstituted aryl group, etc.,; Y represents an oxygen atom, etc.; Z represents an alkylene group, etc.; and W represents an alkyl group, etc.; and pharmacologically acceptable salts thereof and pharmacologically acceptable esters thereof are useful as the active ingredient of pharmaceutical compositions. They may be used to treat specified diseases, including diabetes mellitus, hyperlipemia, arteriosclerosis, hypertension, etc.